Biotech
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 02/12/13 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the t ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 02/12/13 -- Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market its D-Dimer assay. In line wi ...
DALLAS, TX and WARWICK, RI: Enables a Wider Variety of Drugs and Biologically-Based Entities to Be Effectively Used in Implantable Fiber-Based Medical Devices ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwire) -- 02/12/13 -- International Stem Cell Corporation (OTCQB: ISCO) () ("ISCO" or "the Company") a California-based biotechnology company, today announce ...
ROCKVILLE, MD: ROCKVILLE, MD -- (Marketwire) -- 02/12/13 -- Biota Pharmaceuticals, Inc. (NASDAQ: BOTA)Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) today announced its financial results for the three month period ende ...
WINNIPEG, MANITOBA: PreVu Test May One Day Help Monitor Patients on Cholesterol Lowering Medication ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 02/12/13 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...
LEUVEN, BELGIUM: TiGenix to Present at 15th Annual BIO CEO & Investor Conference ...
SAN DIEGO, CA: New Approach for Deep Tissue Imaging of Tumors and Treating Cancer With Thermotherapy Published in PNAS ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 02/11/13 -- Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of best-in-class targeted oncolytic ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 02/11/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced preliminary (unaudited) revenues for the fourth quarter and fiscal year ended December 31, 2012.Full y ...
SAN DIEGO, CA: Paul Cleveland Joins as EVP of Corporate Strategy and Chief Financial Officer ...
SAN FRANCISCO, CA: High-Dose Pexa-Vec Associated With Statistically Significant Improvement in Median Survival Versus Low-Dose Pexa-Vec (14.1 Months vs. 6.7 Months) ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 02/10/13 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, announc ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/08/13 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF)(CNSX: RP) announces that it has received Excha ...
PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 02/08/13 -- The Medicines Company (NASDAQ: MDCO) announced today that the global license and two-year collaboration for Recothrom®, a recombinant thrombin approved ...
SOUTH SAN FRANCISCO, CA: Latest Developments Enable Advanced Tools for Drug Rescue and Potential Cell Therapies Based on Human Definitive Hematopoietic Precursor Cells ...
CAMBRIDGE, MA: Evening Workshop on Using Advanced Mass Spectrometry and Biophysical Methods Follows MassBio's CRO/CMO Symposium on February 25th in Boston ...
CHAPEL HILL, NC: CHAPEL HILL, NC -- (Marketwire) -- 02/07/13 -- (OTCQB: CWNM) is pleased to announce that it has begun to review positive in vivo test results by examining blood plasma levels in test subjects using C ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 02/07/13 -- Toronto-based Integran Technologies Inc. (Integran) today announced its first issued patent pertaining to the use of its metallurgical nano-technologi ...
